David León-Jiménez

7PUBLICATIONS
9CO-AUTHORS
Molecular targetsClinical nutritionFood properties (incl. characteristics and health benefits)Molecular medicineNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 26, 2025
Kidney hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in diabetes: physiology and clinical implications.

David León-Jiménez, Vikas S Sridhar, Manuel López-Mendoza

|Jun 28, 2023
Comprehensive Cardiovascular and Renal Protection in Patients with Type 2 Diabetes.

Almudena Castro Conde, Domingo Marzal Martín, Raquel Campuzano Ruiz

|Aug 27, 2021
Basal insulin analogues in people with diabetes and chronic kidney disease.

David León-Jiménez, José Pablo Miramontes-González, Laura Márquez-López

|May 20, 2020
In response to the paper 'High-protein diet: A barrier to the nephroprotective effects of sodium-glucose co-transporter-2 inhibitors?'

David León-Jiménez, Manuel López-Mendoza, Ramón Pérez-Temprano

|Jan 31, 2019
In response to Yaribeygi et al. "Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways".

David León Jiménez, Fernando Moreno Obregón, José Pablo Miramontes González

|Aug 02, 2018
Antihyperglycemic agents as novel natriuretic therapies in diabetic kidney disease.

David León Jiménez, David Z I Cherney, Petter Bjornstad

Pageof 2